Sommer Kleweno Walley named Harborview's permanent CEO
After a nine-month stint as interim CEO, she will oversee the hospital's $1.74 billion plan for new facilities.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Joey Thompson Source Type: news